CO5130022A1 - Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial - Google Patents
Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacialInfo
- Publication number
- CO5130022A1 CO5130022A1 CO99058020A CO99058020A CO5130022A1 CO 5130022 A1 CO5130022 A1 CO 5130022A1 CO 99058020 A CO99058020 A CO 99058020A CO 99058020 A CO99058020 A CO 99058020A CO 5130022 A1 CO5130022 A1 CO 5130022A1
- Authority
- CO
- Colombia
- Prior art keywords
- drug
- agent
- oralally
- administered
- optionally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Virology (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Una composición farmacéutica en forma de tabletas o cápsulas provee una combinación de control temporal y espacial de la liberación de una droga a un paciente para resultados terapéuticos efectivos. La composición farmacéutica comprende una droga, un componente generador de gas, un agente dilatador, un agente viscoso, y opcionalmente un polímero formador de gel. El agente dilatador pertenece a un grupo de compuestos conocidos como superdesintegradores (por ejemplo: la polivinilpirrolidona de enlace cruzado o la carboximetilcelulosa de sodio). Inicialmente el agente viscoso y luego el polímero formador de gel, forman una matriz de gel hidratada que ocluye el gas, causando que la tableta o cápsula floten para ser retenidas en el estomago o en la parte alta del intestino delgado (control espacial). Al mismo tiempo la matriz de gel hidratado crea un camino de difusión tortuoso para la droga, lo que resulta en una liberación sostenida de la droga (control temporal). Una formulación, preferida, de ciprofloxacin administrada una sola vez al día comprende 69.9% de base de ciprofloxacin, 0.34% de alginato de sodio, 1.03% de goma jantica, 13.7% de bicarbonato de sodio, 12.1% de polivinilpirrolidona de enlace cruzado, y opcionalmente otros excipientes farmacéuticos la formulación esta en forma de tabletas recubiertas o no, o en cápsulas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/152,932 US6261601B1 (en) | 1997-09-19 | 1998-09-14 | Orally administered controlled drug delivery system providing temporal and spatial control |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5130022A1 true CO5130022A1 (es) | 2002-02-27 |
Family
ID=22545063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99058020A CO5130022A1 (es) | 1998-09-14 | 1999-09-14 | Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial |
Country Status (41)
Country | Link |
---|---|
EP (2) | EP1281397A1 (es) |
JP (1) | JP2002524494A (es) |
CN (1) | CN1186013C (es) |
AP (1) | AP1659A (es) |
AR (1) | AR022672A1 (es) |
AT (1) | ATE245414T1 (es) |
AU (1) | AU758324B2 (es) |
BG (1) | BG105339A (es) |
BR (1) | BR9913696A (es) |
CA (1) | CA2343760A1 (es) |
CO (1) | CO5130022A1 (es) |
CU (1) | CU23040A3 (es) |
CZ (1) | CZ2001901A3 (es) |
DE (1) | DE69909801T2 (es) |
DK (1) | DK1107741T3 (es) |
EA (2) | EA004443B1 (es) |
EE (1) | EE200100153A (es) |
ES (1) | ES2204098T3 (es) |
GE (1) | GEP20043216B (es) |
HK (1) | HK1037967A1 (es) |
HR (1) | HRP20010187B1 (es) |
HU (1) | HUP0103632A3 (es) |
ID (1) | ID29843A (es) |
IL (1) | IL141977A0 (es) |
IS (1) | IS5885A (es) |
MX (1) | MXPA01002634A (es) |
MY (1) | MY127952A (es) |
NO (1) | NO20011276L (es) |
NZ (2) | NZ510487A (es) |
OA (1) | OA11652A (es) |
PE (1) | PE20001058A1 (es) |
PL (1) | PL346798A1 (es) |
PT (1) | PT1107741E (es) |
SI (1) | SI1107741T1 (es) |
SK (1) | SK285478B6 (es) |
SV (1) | SV1999000152A (es) |
TR (1) | TR200100731T2 (es) |
UA (1) | UA73287C2 (es) |
UY (1) | UY25710A1 (es) |
WO (1) | WO2000015198A1 (es) |
ZA (1) | ZA995839B (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1263409A1 (en) * | 2000-03-03 | 2002-12-11 | Ranbaxy Laboratories, Limited | Orally administered controlled delivery system for once daily administration of ciprofloxacin |
DE10031043A1 (de) | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
AU2006202275A1 (en) * | 2000-06-26 | 2006-06-22 | Bayer Healthcare Ag | Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
AR030128A1 (es) * | 2000-08-08 | 2003-08-13 | Daiichi Seiyaku Co | Una preparacion solida altamente absorbible |
IN192748B (es) * | 2000-08-29 | 2004-05-15 | Ranbaxy Lab Ltd | |
JP2004513975A (ja) * | 2000-12-05 | 2004-05-13 | マクグレゴール アレキサンダー | 作用物質の制御放出のための静水圧デリバリシステム |
ATE477795T1 (de) | 2001-07-04 | 2010-09-15 | Sun Pharma Advanced Res Co Ltd | Magenretentionssystem mit kontrollierter arzneimittelfreisetzung |
CN1543337A (zh) * | 2001-08-16 | 2004-11-03 | ���ո����ɸߵȽ�����ίԱ�������� | 可膨胀的胃潴留装置 |
US6673369B2 (en) * | 2001-08-29 | 2004-01-06 | Ranbaxy Laboratories Limited | Controlled release formulation |
AU2002351798A1 (en) * | 2001-10-29 | 2003-05-12 | Labopharm Inc. | Methods and dosage forms for improving the bioavailability of therapeutic agents |
RU2322263C2 (ru) * | 2001-11-13 | 2008-04-20 | Астеллас Фарма, Инк. | Система продолжительного высвобождения растворимого лекарственного средства |
ES2259011T3 (es) | 2001-11-19 | 2006-09-16 | Lupin Limited | Composicion farmaceutica para la liberacion controlada de un antibiotico beta-lactama. |
HUP0500217A2 (hu) * | 2002-04-23 | 2005-06-28 | Lupin Limited | Tartós hatású, módosított hatóanyag-leadású mátrix készítmények |
WO2005018613A1 (de) * | 2003-08-26 | 2005-03-03 | Mandapro Ag | Pellets für die orale applikation von pharmazeutischen wirkstoffen |
DE102004042139B4 (de) * | 2004-08-31 | 2009-06-10 | Aristocon Verwaltungs- Gmbh | Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit |
GB0501810D0 (en) * | 2005-01-28 | 2005-03-09 | Pharmakodex Ltd | Chemotherapeutic formulations |
AU2006263338A1 (en) * | 2005-06-29 | 2007-01-04 | Panacea Biotec Ltd. | Pharmaceutical sustained release compositions and processes thereof |
ATE396710T1 (de) * | 2005-07-19 | 2008-06-15 | Ethypharm Sa | Gastroretentive zusammensetzungen und verfahren zur herstellung |
GB0515492D0 (en) * | 2005-07-28 | 2005-08-31 | Reckitt Benckiser Healthcare | Improvements in or relating to compositions,articles and methods |
KR20080076382A (ko) * | 2007-02-15 | 2008-08-20 | (주)아모레퍼시픽 | 실로스타졸의 제어방출 제제 및 그 제조방법 |
WO2010020098A1 (zh) | 2008-08-18 | 2010-02-25 | 北京天衡药物研究院 | 胃滞留药物释出系统及其制备方法和用途 |
ZA200903854B (en) * | 2008-06-19 | 2011-02-23 | Univ Of The Witwatesrand Johannesburg | A gastroretentive pharmaceutical dosage form |
WO2011125075A2 (en) | 2010-04-08 | 2011-10-13 | Fdc Limited | A novel gastroretentive delivery of macrolide |
EP2415460A1 (de) * | 2010-08-03 | 2012-02-08 | ratiopharm GmbH | Orale Darreichungsform von Pregabalin |
TWI705814B (zh) * | 2014-06-20 | 2020-10-01 | 美商梅琳塔有限責任公司 | 醫藥組成物及其用途 |
EP3220894B1 (en) * | 2014-11-19 | 2021-03-10 | DuPont Nutrition USA, Inc. | Nanosuspension formulation |
US10588863B2 (en) | 2017-06-16 | 2020-03-17 | Kashiv Biosciences, Llc | Extended release compositions comprising pyridostigmine |
DK3648747T3 (da) | 2017-06-16 | 2022-11-28 | Amneal Complex Products Res Llc | Gastroretentive doseringsformer til vedvarende frigivelse af lægemidler |
US10987311B2 (en) | 2017-06-16 | 2021-04-27 | Kashiv Specialty Pharmaceuticals, Llc | Extended release compositions comprising pyridostigmine |
EP4056172A1 (en) | 2018-06-18 | 2022-09-14 | Amneal Complex Products Research LLC | Extended release compositions comprising pyridostigmine |
ES2901522T3 (es) | 2018-06-27 | 2022-03-22 | Amneal Complex Products Res Llc | Sistemas de suministro de fármacos gastrorretentivos osmóticos autorregulados |
CN110448535A (zh) * | 2019-09-04 | 2019-11-15 | 湖南宇山玉月农业科技有限公司 | 一种裂褶菌素胃漂浮片 |
CN111116794A (zh) * | 2019-12-20 | 2020-05-08 | 蚌埠市鑫晟新材料科技有限公司 | 一种中性造纸用聚合材料的制备方法 |
CN115715765A (zh) * | 2021-08-24 | 2023-02-28 | 江苏万邦生化医药集团有限责任公司 | 一种悬浮片剂 |
CN113768898A (zh) * | 2021-09-14 | 2021-12-10 | 江苏万邦生化医药集团有限责任公司 | 悬浮的胶囊片 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0798742B2 (ja) * | 1986-07-03 | 1995-10-25 | ゼリア新薬工業株式会社 | 徐放性製剤組成物 |
US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
JPH0624959A (ja) * | 1991-10-04 | 1994-02-01 | Bayer Yakuhin Kk | 胃内浮遊型薬物徐放性固形製剤 |
-
1999
- 1999-01-19 EP EP02023169A patent/EP1281397A1/en not_active Withdrawn
- 1999-01-19 PL PL99346798A patent/PL346798A1/xx unknown
- 1999-01-19 JP JP2000569782A patent/JP2002524494A/ja active Pending
- 1999-01-19 PT PT99900106T patent/PT1107741E/pt unknown
- 1999-01-19 CZ CZ2001901A patent/CZ2001901A3/cs unknown
- 1999-01-19 EA EA200100346A patent/EA004443B1/ru not_active IP Right Cessation
- 1999-01-19 AU AU17794/99A patent/AU758324B2/en not_active Ceased
- 1999-01-19 TR TR2001/00731T patent/TR200100731T2/xx unknown
- 1999-01-19 CA CA002343760A patent/CA2343760A1/en not_active Abandoned
- 1999-01-19 DK DK99900106T patent/DK1107741T3/da active
- 1999-01-19 AP APAP/P/2001/002098A patent/AP1659A/en active
- 1999-01-19 CU CU20010067A patent/CU23040A3/es unknown
- 1999-01-19 IL IL14197799A patent/IL141977A0/xx unknown
- 1999-01-19 AT AT99900106T patent/ATE245414T1/de not_active IP Right Cessation
- 1999-01-19 EE EEP200100153A patent/EE200100153A/xx unknown
- 1999-01-19 CN CNB998129887A patent/CN1186013C/zh not_active Expired - Fee Related
- 1999-01-19 DE DE69909801T patent/DE69909801T2/de not_active Expired - Fee Related
- 1999-01-19 UA UA2001031727A patent/UA73287C2/uk unknown
- 1999-01-19 NZ NZ510487A patent/NZ510487A/xx unknown
- 1999-01-19 ID IDW20010594A patent/ID29843A/id unknown
- 1999-01-19 NZ NZ523747A patent/NZ523747A/en unknown
- 1999-01-19 EP EP99900106A patent/EP1107741B1/en not_active Expired - Lifetime
- 1999-01-19 HU HU0103632A patent/HUP0103632A3/hu unknown
- 1999-01-19 SK SK347-2001A patent/SK285478B6/sk unknown
- 1999-01-19 GE GEAP19995796A patent/GEP20043216B/en unknown
- 1999-01-19 ES ES99900106T patent/ES2204098T3/es not_active Expired - Lifetime
- 1999-01-19 WO PCT/IB1999/000078 patent/WO2000015198A1/en not_active Application Discontinuation
- 1999-01-19 EA EA200300847A patent/EA005767B1/ru not_active IP Right Cessation
- 1999-01-19 MX MXPA01002634A patent/MXPA01002634A/es not_active Application Discontinuation
- 1999-01-19 OA OA1200100064A patent/OA11652A/en unknown
- 1999-01-19 BR BR9913696-1A patent/BR9913696A/pt not_active IP Right Cessation
- 1999-01-19 SI SI9930376T patent/SI1107741T1/xx unknown
- 1999-09-10 ZA ZA9905839A patent/ZA995839B/xx unknown
- 1999-09-13 PE PE1999000924A patent/PE20001058A1/es not_active Application Discontinuation
- 1999-09-13 MY MYPI99003949A patent/MY127952A/en unknown
- 1999-09-13 SV SV1999000152A patent/SV1999000152A/es not_active Application Discontinuation
- 1999-09-14 UY UY25710A patent/UY25710A1/es unknown
- 1999-09-14 CO CO99058020A patent/CO5130022A1/es unknown
- 1999-09-17 AR ARP990104682A patent/AR022672A1/es not_active Application Discontinuation
-
2001
- 2001-03-12 IS IS5885A patent/IS5885A/is unknown
- 2001-03-13 HR HR20010187A patent/HRP20010187B1/xx not_active IP Right Cessation
- 2001-03-13 NO NO20011276A patent/NO20011276L/no unknown
- 2001-03-13 BG BG105339A patent/BG105339A/xx unknown
- 2001-12-11 HK HK01108695A patent/HK1037967A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5130022A1 (es) | Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial | |
YU19501A (sh) | Sistem za kontrolisano davanje lekova oralnim putem koji obezbeđuje vremensku i prostornu kontrolu | |
RU94032150A (ru) | Лекарственное средство с замедленным высвобождением активно-действующего вещества | |
AR004391A1 (es) | Formulacion de liberacion controlada para farmacos basicos escasamente solubles. | |
AU7465087A (en) | Controlled release bioerodible drug delivery system | |
KR20010102088A (ko) | 질에 투여되는 연장방출 생물접착성 겔약형 | |
DE60117801D1 (de) | Pharmazeutische zusammensetzung mit gesteuerter freigabe und verzögerter absorption | |
DE60038536D1 (de) | Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe | |
SG146638A1 (en) | Pharmaceutical delivery system | |
JP2001510795A5 (es) | ||
HN2001000038A (es) | Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina | |
SE9301877D0 (sv) | In situ gel for therapeutic use | |
ECSP993138A (es) | Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial | |
HRP20020258B1 (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | |
EP4217001A1 (en) | Composition and method for prevention and treatment of cutaneous radiation injury | |
DE69803670D1 (de) | Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung | |
NZ703464A (en) | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix | |
HRP20050448A2 (en) | Extended, controlled release pharmaceutical composition comprising charged polymers | |
TH50543A3 (th) | ระบบการนำส่งยาที่ควบคุมได้สำหรับให้ทางปากซึ่งให้การควบคุมเกี่ยวกับเวลาและบริเวณ | |
CO5011086A1 (es) | Budesonida sola o en combinacion con acido ursodesoxicolico en la terapia de enfermedades colestasicas del higado | |
AR043470A2 (es) | Una composicion farmaceutica para ser usada como anticonceptivo | |
AR029327A1 (es) | Uso de la levobupivacaina para la preparacion de medicamentos de aplicacion en el anestesiamiento de pacientes sujetos a intervencion de cirugia mayor |